To give you more details about JITMM2014 & FBPZ8, we have made the abstract book and conference proceedings free to download below. There is also a brief description of our invited speakers.



Online Proceeding 2014


Invited Speakers

Akira Ito

Department of Parasitology, Asahikawa Medical University, Asahikawa, Japan

Emeritus Professsor Ito is a parasitologists at the Asahikawa Medical University, specialising in Cestode zoonoses, mainly echinococcosis, cysticercosis, taeniasis; from field to the laboratory.

Amit Sharma

International Centre for Genetic Engineering and Biotechnology

Dr. Sharma’s laboratory takes a multi-disciplinary approach towards understanding malaria parasite proteins. They aim to highlight the principles that govern biological function of some key parasite proteins. Towards this end, they rely extensively on bioinformatics, biochemistry, cell biology, molecular biology, parasitology and protein crystallography. The current focus of research includes critical parasite processes like invasion of liver and red blood cells, nucleosome assembly, gametocytogenesis and cytoadherence. The laboratory has elucidated crystal structures of key proteins from the sporozoite, asexual and sexual parasite stages.

Arturo Reyes-Sandoval

University Research Lecturer, Wellcome Trust Fellow, NDM Scientific Leadership Fellow, CONACyT SNI II, Group Head / PI, Fellow and Supervisor

Dr. Reyes-Sandoval’s research focuses on the development of a novel malaria vaccine against P. vivax using recombinant viral vectors expressing pre-erythrocytic antigens. Through the support of the Wellcome Trust, I will aim to develop and investigate the following:

  • A novel P. vivax vaccine using recombinant viral vectors expressing pre-erythrocytic antigens.
  • Development of novel transgenic P. berghei parasites expressing P. vivax transgenes that would permit assessment of new vaccine candidates.
  • The ability of viral-vectored vaccines to target the hypnozoites from P. vivax.
  • Design, production and purification of proteins from P. vivax to be used for research and vaccine development.


Brice Campo

Associate Director, Drug Discovery, R&D, Medicines for Malaria Ventures

Dr. Brice Campo leads drug discovery activities in the context of individual projects and pharmacology platforms. Having worked in drug discovery for over 10 years, he has a broad experience in molecular pharmacology as well as drug discovery in Neuroscience, Metabolic Disease and Inflammation.

Bryan K.S. Yeung


Dr. Bryan Yeung is the project manager for the malaria drug discovery portfolio at the Novartis Institute for Tropical Diseases in Signapore. He has been part of the malaria program since its formation in 2007 and has worked on numerous drug discovery programs, most notably NITD609 currently in Phase II clinical trials.

Chang-Kweng Lim

Department of Virology, National Institute of Infectious Disease, Japan

Dr. Lim works as the chief of Laboratory of Neurovirology, Department of Virology, National Institute of Infectious Disease, Japan. His ongoing research focuses on the pathogenesis of Rabies, JC, herpes, Japanese encephalitis, and chikungunya virus Infection.

Dar-der Ji

Department of Tropical Medicine, National Yang-Ming University, Taipei, Taiwan

Dr. Dar-der Ji is the Adjunct Associate Professor at Department of Tropical Medicine in the International Health Program, National Yang-Ming University, Taiwan. His research involves with the Molecular Parasitology, which also expands to transcriptome and genome analysis under the context of Taiwanese patient.

David Sherman

Seattle Biomedical Research Institute

Dr. Sherman is a director of the Tuberculosis Program, and a professor at Seattle Biomedical Research Institute (Seattle Biomed). He is also an Affiliate Associate Professor, Department of Global Health, University of Washington School of Public Health and Community Medicine. His researches are focused on tuberculosis (TB) virulence and drug discovery. His significant publications and accomplishments have been involved with the virulence and latency of Myocbacterium tuberculosis, and engaged in developing novel drugs directed against this tenacious pathogen.

Dennis Kyle

Distinguished University Health Professor Global Health University of South Florida

Dr. Kyle has more than140 publications in the peer-reviewed scientific literature, serves on peer review panels for the National Institutes of Health and the World Health Organization (WHO), chaired the Genomics and Discovery Research Steering Committee and the Compound Evaluation Network for WHO, and has research funding from NIAID, the Bill and Melinda Gates Foundation, and Medicines for Malaria Venture. His research interests include the discovery and development of new antiparasitic drugs and elucidation of mechanisms of antimalarial drug resistance. Predoctoral training opportunities in the Kyle Lab include basic and translational approaches to drug discovery and development as well as chemical biology of antiparasitic drugs and elucidation of drug resistance mechanisms. All of the current projects in the Kyle Lab are multidisciplinary and result in active collaborations with colleagues in chemistry, molecular biology, pharmacology, and clinical practice

Didier Ménard

International Network of Pasteur Institutes - Senior Researcher Head of the Malaria Molecular Epidemiology Unit - Pasteur Institute of Cambodia

International Network of Pasteur Institutes - Senior Researcher Head of the Malaria Molecular Epidemiology Unit - Pasteur Institute of Cambodia.

Dr. Menard’s main research projects conducted since 2003 are aimed at improving our knowledge of the malaria situation (infection and disease), at assessing tools used to control and/or eliminate this disease in particular with regard to polymorphisms of the local parasite populations and at developing improved assessment tools.

Duangduen Krailas

Department of Biology, Faculty of Science, Silpakorn University

Dr. Krailas is an Associate Professor at the Department of Biology, Faculty of Science, Silpakorn University. Her research is in parasitology and malacology, especially on the biology of human intestinal flukes.

Dung Trung Do

Department for Parasitology, National Institute of Malariology, Parasitology and Entomology (NIMPE), Hanoi, Vietnam

Dr. Do is a medical doctor and head of the Parasitology Department, National Institute of Malariology Parasitology and Entomology, Hanoi, Vietnam. He has more than 10 years’ experience working on neglected tropical diseases (NTDs), including soil-transmitted helminthes (STH), lymphatic filariasis (LF), foodborne trematode infections and taeniasis/cysticercosis.

Florence Robert-Gangneux

Professor at the Faculty of Medicine of Rennes (University Rennes-1, France)

Dr. Florence Robert-Gangneux is Professor of Parasitology and Mycology at the Faculty of Medicine of Rennes (University Rennes-1, France). She is a medical biologist who has more than 20 years’ experience in the field of toxoplasmosis, and is in charge of immunological and molecular diagnosis of toxoplasmosis and other parasitic diseases at the University Hospital of Rennes.

Francois Nosten

Professor in Tropical Medicine, Director of the Shoklo Malaria Research Unit, Group Head / PI, Consultant Physician and Fellow

Nosten’s work concentrates on uncomplicated malaria and he has conducted the largest ever drug trials in malaria in an area which has the world’s most drug-resistant parasites, including a detailed study of the SPf66 malaria vaccine. Recent studies have concentrated on the efficacy and effectiveness of combination anti malarial therapy. Dr Nosten has also investigated malaria prophylaxis and antimalarial treatment in pregnancy and the identification of thiamine deficiency (beri-beri) as a major cause of infant mortality amongst Karen refugees

Ivo Mueller

Research Professor at CRESIB and the Walter & Eliza Hall Institute in Melbourne

Professor Ivo Mueller is currently conducting population-based malaria studies for the control and eventual elimination of malaria by bridging from basic Plasmodium biology to clinical development of new interventions. A special focus lies on studying the P. vivax host-parasite interaction and his group is recognised as one of the best in studying the epidemiology of P. vivax.

Jaishree Paul

School of Life Sciences, Jawaharlal Nehru University, India

Prof. Paul is a microbiologist at the School of Life Sciences, Jawaharlal Nehru University, with over three decades’ research experience. Her research interests include the interplay between gut bacteria during Inflammatory Bowel Disease, epidemiology of intestinal parasites – Entamoeba, Giardia and Cryptosporidium, and fuctional analysis of susceptible genes of IBD.

James F. Kelley

Department of Tropical Medicine, Medical Microbiology and Pharmacology, University of Hawaii

Dr. Kelley received the Fogarty Global Health Fellowship Program, NIH, to investigate molecular and immunological aspects of viruses with the goal of delineating mechanisms of pathogenesis. His work is performed in collaboration with the Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University.

Jetsumon (Sattabongkot) Prachumsri

Director of Mahidol Vivax Research Center at and Deputy Dean for Research at Mahidol University Faculty of Tropical Medicine

Dr. Prachumsri is the Director of Mahidol Vivax Research Center at Mahidol University, and the Deputy Dean for research at the Faculty of Tropical Medicine. Her research specialisation is in malaria, and malaria vector biology. Prior to joining the MVRC, Dr. Jetsumon was Chief of the Laboratory Science Section, Department of Entomology, U.S.A. Medical Component, Armed Forces Research Institute of Medical Science, Bangkok.

John Adams

Professor at University of South Florida, Tampa

Professor Adams’ research focuses on the biology of malaria parasites, particularly Plasmodium falciparum and P. vivax which cause the majority of human malarial cases. Major questions of his lab’s research include: a) how allelic variation in the ligands helps the parasite evade inhibitory immunity; b) what are the molecular interactions of the malarial ligand that are important to its function; and c) what mechanisms control expression of the invasion-related genes.

Kesinee Chotivanich

Associate Professor at Mahidol-Oxford Tropical Medicine Research Unit

Kesinee Chotivanich is an associate professor at the Mahidol-Oxford Tropical Medicine Research Unit. Her fields of expertise include the pathophysiology of malaria, cultivation of human malaria parasites, and in vitro susceptibility drugs of P. falciparum, P. Vivax.

Lisa White

MAEMOD (Mathematical And Economic Modelling) MORU (Mahidol-Oxford Tropical Medicine Research Unit)

Prof. White is the head of an MAEMOD based at MORU in Bangkok. MAEMOD coordinates an international network of infectious disease modellers and modelling research beneficiaries working in the Tropics. Her work on malaria combines within and between host infection models with multi-strain/species modelling to consider the characterisation, emergence, and spread of antimalarial drug resistance and ints containment.

Liwang Cui

Professor of Entomology, Penn State University, College of Agricultural Sciences

Prof. Cui’s lab focuses on malaria research – he was awarded a 14.5 million USD grant to fight malaria in Southeast Asia in 2010, and the lab is currently working on several projects:

  • Malaria parasite developmental biology
  • Malaria parasite epigenetics
  • Malaria epidemiology and population biology
  • Mechanisms of drug resistance


Marcel Tanner

Professor, Epidemiologist, MPH, Director of the Swiss Tropical and Public Health Institute

Marcel Tanner obtained a PhD on medical biology from the University of Basel and a MPH from the University of London. He is Director of the Swiss Tropical and Public Health Institute and Professor of Epidemiology and Medical Parasitology at the University of Basel and at the Federal Institute of Technology. Since 1977, his research ranges from basic research on the cell biology and immunology on malaria, schistosomiasis, trypanosomiasis and filariasis to epidemiological and public health research on risk assessment, vulnerability, health impact and district health planning. His research, teaching and health planning expertise are based on substantial long term experience from working in rural and urban areas in Africa (mainly Tanzania, Chad, Burkina Faso and Côte d’Ivoire) and Asia (China, Thailand, Laos).

Michael White

Faculty of Medicine, School of Public Health, University College London

Dr. White received the MRC Research Fellow to join the Department of Infectious Disease Epidemiology in Imperial College London working on Plasmodium vivax malaria. His works involve in an understanding of the mathematical models to investigate the contribution of relapse infections to the epidemiology and control of P. vivax malaria.

Narong Khuntikeo

Associate Professor at the Department of Surgery and Liver Fluke and Cholangiocarcinoma Research Center, Faculty of Medicine, Khon Kaen University

Dr. Khuntikeo is an Associate Professor at the Department of Surgery, Faculty of Medicine, Khon Kaen University. He works at the Liver Fluke and Cholangiocarcinoma Research Center (Liver Care), and his multidisciplinary research contributes to a better understanding of carcinogenesis, parasite-host interaction, specific diagnosis, targeted therapy and improvement of quality of life for patients.

Nicholas J. White

Professor of tropical medicine, Group Head/PI, Consultant Physician, Fellow, Member of Congregation and Supervisor at Mahidol Oxford Tropical Medicine Research Unit

Professor White’s diverse interests include the epidemiology, pathophysiology and management of uncomplicated and severe malaria, meliodosis, enteric fever, tetanus, dengue haemorrhagic fever, Japanese encephalitis and tuberculosis. His particular interests at present include the pathophysiology and treatment of severe malaria, the prevention of antimalarial drug resistance using artemisinin-based combinations, and the biology of relapse in vivax malaria.

Omar Vandal

Bill & Melinda Gates Foundation

Omar Vandal is a member of the Bill & Melinda Gates Foundation's Drug Discovery team, where he is primarily involved in developing and managing early stage drug discovery investments in TB, malaria, and the Grand Challenges Explorations program.

Omar previously worked for the TB Alliance, where he served as Secretariat for the WHO Working Group on New TB Drugs. He completed post-doctoral work and his PhD at Weill Medical College of Cornell University in New York City. Omar's work at Cornell focused on interactions of Mycobacterium tuberculosis with the host and led to the identification of novel pathways and potential drug targets required for pathogenesis of TB. In his spare time, Omar co-founded a film production company and non-profit organization to promote science education in his native Pakistan.

Paiboon Sithithaworn

Department of Parasitology and Liver Fluke and Cholangiocarcinoma Research Center, Faculty of Medicine, Khon Kaen University

lecturer in Parasitology at the Faculty of Medicine, Khon Kaen University since 1979 and joined the Liver Fluke and Cholangiocarcinoma Research Center (LFCRC) in 2002. The research center was established by the University in order to combat the liver fluke and cholangiocarcinoma through research and education

Podjanee Jittamala

Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University

Dr. Jittamala is a researcher at the Department of Tropical Hygiene, specializing in pediatric infectious diseases.

Pradip Rathod

Director, NIH International Center of Excellence for Malaria Research for South Asia (South Asia ICEMR)

The Rathod group is targeting high-value pyrimidine biosynthesis enzymes with selectivity by starting with host-parasite protein differences at the active-site, by appropriate pro-drugs, by supplementing non-selective antifolates with rescuing nutrients that only the host can use, or by disrupting unique protein-protein interactions. The enzymes targeted by the group are malarial thymidylate synthase and dihydroorotate dehydrogenase (the latter with M. Phillips at the University of Texas Southwestern Medical Center).

Prasit Palittapongarnpim

Department of Microbiology, Faculty of Science, Mahidol University

Dr. Prasit is a professor in Department of Microbiology, Faculty of Science. His main research interest is on molecular biology and epidemiology of Mycobacterium. He has contributed to the development of VNTR (Variable Number of Tandem Repeat) typing, which is becoming a standard genotyping tool of M. tuberculosis, and pioneers the works on the biological functions of the VNTR. His researches also involve with the screening of natural compounds for antituberculous activity, the identification of drug targets, the development of antituberculous screening methods and the identification of species of mycobacteria.

Priyadarshi Soumyaranjan Sahu

Senior Lecturer, International Medical University Malaysia

Dr. Sahu is currently a medical faculty and researcher affiliated to the School of Medicine, International Medical University, Kuala Lumpur (Malaysia). Presently he is interested in understanding disease pathogenesis, diagnostic development, and sero-epidemiological aspects of Taenia solium cysticercosis, tuberculosis, and other tropical infectious diseases affecting brain. His interest also lies in exploring the possibility of different systemic factors contributing to the organ damage events during bacterial sepsis.

Rahmah Noordin

Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia

Prof. Rahmah Noordin’s research focus is on the discovery studies of diagnostic markers for infectious diseases (particularly parasitic diseases) using molecular biology and proteomics tools; recombinant protein production; cell culture and parasite in-vitro and in-vivo culture; cDNA library immuno-screening; investigation of in-vivo induced antigens; protein and DNA-based assay development including lateral flow rapid prototype test development and validation.

Rapatbhorn Patrapuvich

Postdoc Fellow, Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University

Dr. Patrapuvich is a researcher at the Mahidol Vivax Research Unit, and her speciality is in liver stage Plasmodium vivax. She is currently involved with MVRU’s liver stage drug discovery program.

Smarn Tesana

Food-Borne Parasite Research Group, Department of Parasitology, Faculty of Medicine, Khon Kaen University

Dr. Tesana is an Associate Professor at the Department of Parasitology, Faculty of Medicine, Khon Kaen University. His works contributes toward the better understanding of the liver fluke in the Northeastern villages of Thailand.

Stefan Kappe

Seattle Biomedical Research Institute

Stefan Kappe’s laboratory is focused on the biology of the malaria parasite pre-erythrocytic stages: the mosquito stage and the mammalian liver stage. The goal of the lab is to understand liver stage parasite development and elucidate networks of host-parasite interactions during liver stage infection. We utilize this knowledge to develop new interventions, both drugs and vaccines. Dr. Kappe received a prestigious Grand Challenges in Global Health grant from the Bill & Melinda Gates Foundation in 2005, which is targeted at designing genetically engineered, live attenuated Plasmodium falciparum vaccine strains. Dr. Kappe's genetically attenuated parasite (GAP) vaccine strain is currently undergoing clinical testing.

Suparat Phuanukoonnon

Senior Research Fellow at the Walter and Eliza Hall Institute of Medical Research, Australia and at Papua New Guinea Institute of Medical Research, Papua New Guinea

Dr. Phuanukoonnon is a senior research fellow at both Walter and Eliza Hall Institute of Medical Research, and at the Papa New Guinea Institute of Medical Research. She specialises in public health, epidemiology, health promotion and environmental health.

Thanat Chookajorn

Faculty of Tropical Medicine, Mahidol University

Dr. Thanat Chookajorn received his Ph.D. degree from Cornell University under the supervision of Professor June Nasrallah. He continued his research career as a postdoctoral fellow in the laboratory of Professor Daniel Hartl at Harvard University.

Currently, his research goal is to understand how multi-copy genes or alleles systemically work together as one sinle unit. Reseacrh questions in his laboratory involve malaria, thalassemia, and protein evolution.

Tiengkham Pongvongsa

Section of Malariology, Parasitology and Entomology, Savannakhet, Lao PDR

Dr. Pongvongsa is the director of Malariology, Parasitology and Entomology Section and the Head of the Coordination Committee for Health Science Research at Savannakhet provincial Health Department, Lao PDR. His work is involved with the Parasitic diseases Control in Savannakhet.

Timothy Henry Holtz

Director of Silom Community Clinic @ TropMed, Thailand MOPH - US CDC Collaboration (TUC)

Dr. Timothy Henry Holtz is director of HIV/STD Research Program, Thailand MOPH – US. CDC Collaboration (TUC). This fruitful collaboration gives an outcome of the Silom Community Clinic @ TropMed. Dr. Holtz serves as the director of this clinic which locates at the Hospital for Tropical Disease. His research interests cover with the HIV/STD Prevention Research that consists of Pre-Exposure Prophylaxis, Rectal microbicides, and HIV vaccine trials.

Tomoyoshi Nozaki

Director, Department of Parasitology, National Institute of Infectious Diseases

Prof Nozaki’s major research areas include the pathogenesis of parasitic protozoa, biochemistry of sulfur-containing metabolism of parasitic protozoa and drug development, vesicular trafficking of virulence factors and phagocytosis Evolution, and the function of mitochondrion-related organelles in anaerobic protozoa.

Veeranoot Nissapatorn

Associate Professor, Department of Parasitology, Faculty of Medicine, University of Malaya, Malaysia

Dr. Nissapatorn is an Associate Professor at the Department of Parasitology, Faculty of Medicine, University of Malaya, Malaysia. Among many routine and research activities, she is involved with the Southeast Asia Team related to Water, Toxoplasmosis and Neglected Tropical Diseases, which was founded in 2011.

Wai-Hong Tham

Division of Infection and Immunity, Walter and Eliza Hall Institute of Medical Research

Dr. Tham’s lab is interested in how malaria parasites exploit or evade the complement system for successful infection of the human host. She specialises particularly in complement evasion strategies of malaria parasites and investigation of complement receptors as entry points for malaria parasites.

Wang Nguitragool

Lecturer, Department of Molecular Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University

Dr. Nguitragool is a researcher at the Faculty of Tropical Medicine, Mahidol University. His field of expertise is in malaria, membrane protein biochemistry, physiology and molecular biology. He is a Wellcome Trust fellow currently studying the mechanism of reticulocyte-specific invasion by Plasmodium vivax.

Yong Hoi Sen

Institute of Biological Sciences, University of Malaya, 50603 Kuala Lumpur, Malaysia

Dr. Sen has been Professor Emeritus from University of Malaya since 2007. He is a Senior Fellow of the Academy of Sciences Malaysia and a recipient of the Merdeka Award 2010 for Outstanding Scholastic Achievement. His researches is involved with Biodiversity, Genetics, immunology and molecular biology of parasites, vectors and hosts.

Yong Poovorawan

Director of the Center of Excellence in Viral Hepatitis Research and Molecular Biology Research, Faculty of Medicine, Chulalongkorn University

Professor Yong Poovorawan is a professor in Pediatric hepatology and virology at the Faculty of Medicine of Chulalongkorn University in Bangkok, Thailand. He is widely noted for his research in the fields of pediatric hepatology, viral hepatitis and virology, and is regarded as a subject expert on the H5N1 avian influenza virus in Thailand.